Decibel expands global footprint into UK Medical Cannabis market
Canada-based Decibel is expanding its global footprint through a new supply agreement to provide premium dried medical cannabis flower to the United Kingdom’s 4C LABS.
4C Labs is a healthcare, technology and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis-based medicinal products in the UK.
Under the three-year agreement, Decibel will supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients, granting strain exclusivity of rare and unique cultivars.
Adam Coates, Chief Revenue Officer at Decibel, commented: “We are excited to partner with 4C LABS, a leading organisation in the growing medical cannabis industry in the UK, that echoes Decibel’s commitment to quality and patient care.
“Not only will this unlock a strong partnership and a new market for Decibel’s craft cannabis products, it also sets the stage for further growth into other European markets.
“Decibel’s success with Qwest flower products in Canada and in Israel’s medical market reinforces the demand for premium cannabis products and the reputation we have built to service that demand.”
Greg Dobbin, CEO 4C LABS added: “4C LABS is building a patient-focused best-in-class product line for the UK & Channel Islands, the Qwest craft flower line strengthens the top end of the 4C LABS product offerings.
“Decibel’s innovative craft quality Qwest flower products will fill an empty segment in the UK market and bring a world-class BC Cannabis product to UK patients.
“Decibel’s success in Canada, the most competitive cannabis market in the world, is a product of hard work, innovation and attention to detail, qualities that will resonate with UK patients.”